<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Dyspepsia (incl. suspected upper GI cancer triggers) — DGRefHelp Drafts</title>
  <link rel="stylesheet" href="../assets/site.css" />
</head>
<body>
  <div class="container">
    <div class="header">
      <div class="brand">
        <h1><a href="../index.html">DGRefHelp drafts</a> / Dyspepsia</h1>
        <div class="sub">Adults with dyspepsia/reflux: identify emergency red flags, apply NG12 suspected cancer pathway triggers (dysphagia; ≥55 + weight loss + epigastric pain/reflux/dyspepsia), use NICE CG184 first‑line management (PPI and/or H. pylori test‑and‑treat), and safety‑net persistent symptoms.</div>
      </div>
      <div class="badges">
        <div class="badge">Mode: quick</div>
        <div class="badge">Last updated: 2026‑02‑11</div>
      </div>
    </div>

    <div class="grid">
      <div class="card">
        <div class="card-hd">
          <div class="tabs" data-tabs>
            <button class="tab" role="tab" data-tab="evidence" aria-selected="true">Evidence</button>
            <button class="tab" role="tab" data-tab="draft" aria-selected="false">DGRefHelp draft</button>
            <button class="tab" role="tab" data-tab="refs" aria-selected="false">References</button>
          </div>
          <div class="copybar">
            <button class="btn" data-copy-target="#draftText">Copy draft</button>
            <button class="btn" data-copy-target="#evidenceText">Copy evidence</button>
          </div>
        </div>

        <div class="card-bd">
          <div class="panel active" role="tabpanel" data-panel="evidence">
            <div id="evidenceText" class="section">
<h3>Evidence summary (triangulated)</h3>

              <div class="callout ok">
                <strong>Key design points (primary care)</strong>
                <ul>
                  <li><strong>Suspected cancer pathway referral (NICE NG12):</strong> refer for oesophageal cancer if <strong>dysphagia</strong>, or if <strong>age ≥55 + weight loss</strong> plus any of: <strong>upper abdominal pain</strong>, <strong>reflux</strong>, or <strong>dyspepsia</strong>. The same trigger applies for <strong>stomach cancer</strong> in NG12.</li>
                  <li><strong>Non-urgent direct-access endoscopy (NG12):</strong> consider for <strong>haematemesis</strong>, and for <strong>age ≥55</strong> with <strong>treatment‑resistant dyspepsia</strong> (and several other symptom/test combinations such as low Hb with upper abdominal pain; thrombocytosis plus upper GI symptoms; or nausea/vomiting plus weight loss/reflux/dyspepsia/upper abdominal pain).</li>
                  <li><strong>Same-day specialist assessment (CG184):</strong> dyspepsia with <strong>significant acute GI bleeding</strong> → immediate same‑day referral (also see NICE CG141 acute upper GI bleeding).</li>
                  <li><strong>Initial management of uninvestigated dyspepsia (CG184):</strong> offer <strong>full‑dose PPI for 4 weeks</strong> and/or <strong>H. pylori “test and treat”</strong>. Leave a <strong>2‑week PPI washout</strong> before breath test or stool antigen test for H. pylori.</li>
                  <li><strong>Don’t miss differentials (CG184):</strong> review meds that can cause dyspepsia (e.g. NSAIDs, bisphosphonates, steroids) and consider <strong>cardiac</strong> or <strong>biliary</strong> disease where appropriate.</li>
                </ul>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="draft">

            <div class="callout" style="margin-bottom:12px">
              <strong>Copy/paste HTML for Right Decisions accordion sections</strong>
              <div class="small">Per your preference, these snippets contain section content only (no internal headings). Paste each into the matching accordion section.</div>
              <div style="height:10px"></div>
              <div class="copybar" style="justify-content:flex-start">
                <button class="btn" data-copy-target="#htmlBackground">Copy Background HTML</button>
                <button class="btn" data-copy-target="#htmlAssessment">Copy Assessment HTML</button>
                <button class="btn" data-copy-target="#htmlPCM">Copy Primary care mgmt HTML</button>
                <button class="btn" data-copy-target="#htmlRefer">Copy Who to refer HTML</button>
                <button class="btn" data-copy-target="#htmlNotRefer">Copy Who not to refer HTML</button>
                <button class="btn" data-copy-target="#htmlRefs">Copy References HTML</button>
              </div>

              <details style="margin-top:10px">
                <summary class="small" style="cursor:pointer">Show HTML snippets</summary>

                <h4 style="margin:12px 0 6px">Background (HTML)</h4>
                <pre id="htmlBackground">&lt;ul&gt;&lt;li&gt;(Add 1–3 background bullets if desired.)&lt;/li&gt;&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Assessment (primary care) (HTML)</h4>
                <pre id="htmlAssessment">&lt;ul&gt;
                &lt;li&gt;&lt;strong&gt;Haemodynamic compromise&lt;/strong&gt;, collapse/syncope, or suspected major upper GI bleed.&lt;/li&gt;
                &lt;li&gt;&lt;strong&gt;Severe/ongoing haematemesis&lt;/strong&gt; or melaena with systemic upset.&lt;/li&gt;
                &lt;li&gt;&lt;strong&gt;Suspected perforation&lt;/strong&gt;: sudden severe pain, rigid abdomen, peritonism.&lt;/li&gt;
                &lt;li&gt;&lt;strong&gt;Acute coronary syndrome mimic&lt;/strong&gt;: central chest pain/pressure, breathlessness, diaphoresis (treat as cardiac until proven otherwise).&lt;/li&gt;
              &lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Primary care management (HTML)</h4>
                <pre id="htmlPCM">&lt;ul&gt;
                &lt;li&gt;Check for drugs that can cause/worsen dyspepsia (e.g. &lt;strong&gt;NSAIDs&lt;/strong&gt;, bisphosphonates, steroids, calcium antagonists, nitrates, theophyllines).&lt;/li&gt;
                &lt;li&gt;If referring, &lt;strong&gt;suspend NSAIDs&lt;/strong&gt; where possible (CG184).&lt;/li&gt;
              &lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Who to refer (HTML)</h4>
                <pre id="htmlRefer">&lt;ul&gt;
                &lt;li&gt;&lt;strong&gt;Dysphagia&lt;/strong&gt; → refer using suspected cancer pathway (oesophageal and/or stomach cancer framing) (NICE NG12).&lt;/li&gt;
                &lt;li&gt;&lt;strong&gt;Age ≥55 + weight loss&lt;/strong&gt; + any of:
                  &lt;ul&gt;
                    &lt;li&gt;&lt;strong&gt;upper abdominal pain&lt;/strong&gt;&lt;/li&gt;
                    &lt;li&gt;&lt;strong&gt;reflux&lt;/strong&gt;&lt;/li&gt;
                    &lt;li&gt;&lt;strong&gt;dyspepsia&lt;/strong&gt;&lt;/li&gt;
                  &lt;/ul&gt;
                  → refer using suspected cancer pathway (NICE NG12; amended 2025).
                &lt;/li&gt;
              &lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Who not to refer (HTML)</h4>
                <pre id="htmlNotRefer">&lt;ul&gt;&lt;li&gt;(If no explicit ‘who not to refer’ applies, omit or keep minimal.)&lt;/li&gt;&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">References (HTML)</h4>
                <pre id="htmlRefs">&lt;ol&gt;&lt;li&gt;(Add references here.)&lt;/li&gt;&lt;/ol&gt;</pre>
              </details>
            </div>

            <div id="draftText" class="section">
<h3>Dyspepsia / reflux symptoms — adults (NG12 + CG184 framing)</h3>

              <h4>Immediate red flags (999 / ED now)</h4>
              <ul>
                <li><strong>Haemodynamic compromise</strong>, collapse/syncope, or suspected major upper GI bleed.</li>
                <li><strong>Severe/ongoing haematemesis</strong> or melaena with systemic upset.</li>
                <li><strong>Suspected perforation</strong>: sudden severe pain, rigid abdomen, peritonism.</li>
                <li><strong>Acute coronary syndrome mimic</strong>: central chest pain/pressure, breathlessness, diaphoresis (treat as cardiac until proven otherwise).</li>
              </ul>

              <h4>Same-day specialist assessment</h4>
              <ul>
                <li><strong>Significant acute GI bleeding</strong> with dyspepsia → same‑day specialist assessment (NICE CG184; see also NICE CG141 acute upper GI bleeding).</li>
              </ul>

              <h4>Suspected cancer pathway referral (2WW equivalent) — NG12</h4>
              <ul>
                <li><strong>Dysphagia</strong> → refer using suspected cancer pathway (oesophageal and/or stomach cancer framing) (NICE NG12).</li>
                <li><strong>Age ≥55 + weight loss</strong> + any of:
                  <ul>
                    <li><strong>upper abdominal pain</strong></li>
                    <li><strong>reflux</strong></li>
                    <li><strong>dyspepsia</strong></li>
                  </ul>
                  → refer using suspected cancer pathway (NICE NG12; amended 2025).
                </li>
              </ul>

              <h4>Non-urgent direct-access upper GI endoscopy — NG12 (examples)</h4>
              <ul>
                <li><strong>Haematemesis</strong> → consider non-urgent direct-access upper GI endoscopy (NG12).</li>
                <li><strong>Age ≥55 with treatment‑resistant dyspepsia</strong> → consider non-urgent direct-access endoscopy (NG12).</li>
                <li><strong>Age ≥55 with upper abdominal pain + low Hb</strong> → consider non-urgent direct-access endoscopy (NG12).</li>
                <li><strong>Age ≥55 with thrombocytosis</strong> plus upper GI symptoms (nausea/vomiting/weight loss/reflux/dyspepsia/upper abdo pain) → consider endoscopy (NG12).</li>
                <li><strong>Nausea/vomiting</strong> with weight loss/reflux/dyspepsia/upper abdo pain (age ≥55) → consider endoscopy (NG12).</li>
              </ul>

              <h4>Step 1 — define the presentation (don’t anchor too early)</h4>
              <ul>
                <li>Symptoms: epigastric pain/burning, post-prandial fullness, early satiety, heartburn, acid regurgitation, nausea/vomiting, bloating.</li>
                <li>Duration and trajectory: new vs chronic; progressive vs intermittent; response to OTC antacids/alginate.</li>
                <li>Risk factors / context: NSAID use, alcohol, smoking, known ulcer disease, previous endoscopy results.</li>
                <li>Consider differentials: biliary colic, pancreatitis, cardiac causes, pregnancy, medication-induced oesophagitis.</li>
              </ul>

              <h4>Step 2 — medication review (CG184)</h4>
              <ul>
                <li>Check for drugs that can cause/worsen dyspepsia (e.g. <strong>NSAIDs</strong>, bisphosphonates, steroids, calcium antagonists, nitrates, theophyllines).</li>
                <li>If referring, <strong>suspend NSAIDs</strong> where possible (CG184).</li>
              </ul>

              <h4>Step 3 — initial management of uninvestigated dyspepsia (CG184)</h4>
              <ul>
                <li>Offer <strong>full‑dose PPI for 4 weeks</strong> (CG184).</li>
                <li>Offer <strong>H. pylori test-and-treat</strong> (CG184).</li>
                <li><strong>H. pylori testing:</strong> if using breath test or stool antigen test, ensure a <strong>2‑week washout after PPI</strong> (CG184).</li>
                <li>If symptoms recur: step down to <strong>lowest effective dose</strong> / <strong>as‑needed</strong> use where appropriate (CG184).</li>
                <li>If inadequate response to PPI: consider an <strong>H2 receptor antagonist</strong> (CG184).</li>
              </ul>

              <h4>Step 4 — safety-netting (pragmatic)</h4>
              <ul>
                <li>Give clear advice to return urgently if <strong>dysphagia</strong>, <strong>weight loss</strong>, <strong>persistent vomiting</strong>, <strong>melaena/haematemesis</strong>, <strong>anaemia symptoms</strong>, or escalating pain/systemic illness.</li>
                <li>Plan review if symptoms persist after initial treatment (e.g. after the 4‑week PPI trial), and reassess for NG12 criteria.</li>
              </ul>

              <h4>Who to refer / where to send (D&amp;G placeholders)</h4>
              <ul>
                <li><strong>999 / ED</strong>: unstable/major bleed, perforation concern, severe systemic illness, ACS mimic.</li>
                <li><strong>Same-day specialist</strong>: significant acute GI bleeding with dyspepsia (CG184/CG141).</li>
                <li><strong>Suspected cancer pathway</strong>: dysphagia; or ≥55 + weight loss + (upper abdo pain/reflux/dyspepsia) (NG12).</li>
                <li><strong>Direct-access endoscopy (non-urgent)</strong>: haematemesis; or ≥55 with treatment‑resistant dyspepsia; and other NG12 combinations (local route).</li>
                <li><strong>Routine gastro</strong>: persistent symptoms without NG12 triggers despite appropriate initial management (local route).</li>
              </ul>

              <h4>Referral-letter minimum (suggested)</h4>
              <ul>
                <li>Symptoms (exact description), onset date, progression, presence/absence of <strong>dysphagia</strong> and <strong>weight loss</strong>.</li>
                <li>Bleeding features: melaena/haematemesis; anticoagulant/antiplatelet use.</li>
                <li>Medications and risk factors (esp. NSAIDs, bisphosphonates, steroids, smoking, alcohol).</li>
                <li>Treatments tried: PPI course (dose/duration), H. pylori test result and eradication regimen if given.</li>
              </ul>

              <h4>Local agreement needed (add D&amp;G specifics)</h4>
              <ul>
                <li class="check">Local referral route for NG12 upper GI suspected cancer triggers: direct-to-endoscopy vs clinic-first.</li>
                <li class="check">Define “treatment‑resistant dyspepsia” operationally (duration, PPI dose, adherence) for direct-access endoscopy referrals.</li>
                <li class="check">Preferred local <strong>H. pylori test</strong> (breath vs stool antigen) and any local lab constraints; confirm PPI washout expectations.</li>
                <li class="check">Local first-line <strong>H. pylori eradication</strong> regimen (antimicrobial stewardship / resistance considerations; prior macrolide exposure policy).</li>
                <li class="check">Local pathway for significant dyspepsia with bleeding features: ED vs acute assessment unit vs gastro hot clinic.</li>
              </ul>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="refs">
            <div class="section">
              <h3>References (retrieved 2026‑02‑06)</h3>
              <ol>
                <li>RCOG Green‑top Guideline No. 34: Ovarian Cysts in Postmenopausal Women (consensus update Dec 2025; web page last reviewed 05 Dec 2025). <a href="https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/ovarian-cysts-in-postmenopausal-women-green-top-guideline-no-34/">rcog.org.uk</a></li>
                <li>NICE NG12: Suspected cancer — recommendations organised by site of cancer (ovarian cancer section; CA‑125 ≥35 → USS). <a href="https://www.nice.org.uk/guidance/ng12/chapter/Recommendations-organised-by-site-of-cancer">nice.org.uk</a></li>
                <li>Right Decisions (GGC primary care): Ovarian cysts in post-menopausal women (example of local thresholds/RMI approach; not D&amp;G). <a href="https://www.rightdecisions.scot.nhs.uk/ggc-primary-care/womens-health/gynaecology-clinical-guidelines/ovarian-cysts-in-post-menopausal-women-549/">rightdecisions.scot.nhs.uk</a></li>
              </ol>
            </div>
          </div>

        </div>
      </div>

      <div class="footer">
        <a href="../index.html">← Back to topics</a>
      </div>
    </div>
  </div>

  <script src="../assets/site.js"></script>
</body>
</html>
